ADM treatment suppressed TNF-α/IFN-γ- (TI-) induced TARC, MDC, IL-6, and ICAM-1 expression in HaCaT keratinocytes, which suggests ADM might exert a therapeutic effect by downregulating levels of AD-related factors in keratinocytes. The gene discussed is TNF; the disease is Alzheimer disease.